Yahoo Search Busca da Web

Resultado da Busca

  1. This Metastatic Colorectal Cancer (mCRC)- Epidemiology Forecast-2032 report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

  2. 27 de mai. de 2023 · Our current study forecasts that the heterogeneity of metastatic cancer will evolve, driven by significant alterations in the incidence of lung, colorectal, and breast cancers.

  3. 29 de abr. de 2022 · This Metastatic Colorectal Cancer (mCRC)- Epidemiology Forecast-2032 report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC...

  4. 25 de out. de 2022 · Highlights. •. This ESMO Clinical Practice Guideline provides key recommendations for managing metastatic colorectal cancer. •. It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. •. Treatment algorithms for locoregional, advanced/metastatic and recurrent advanced colorectal cancer are provided. •.

  5. 4 de abr. de 2024 · Abstract. This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC).

  6. 22 de abr. de 2021 · Epidemiological data indicate that an increasing colorectal cancer incidence in developed and developing countries may be the result of a sedentary lifestyle. It is estimated that physically inactive people have up to 50% higher risk of developing colorectal cancer in comparison to the most physically active ones [17,52].

  7. 25 de out. de 2022 · INCIDENCE AND EPIDEMIOLOGY Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new cases per year, and is the second leading cause of cancer death.1 CRC occurs more frequently in middle- to high-income countries with an eightfold variation in incidence across the world. This rise